Page last updated: 2024-09-05

sb 216763 and Drug Withdrawal Symptoms

sb 216763 has been researched along with Drug Withdrawal Symptoms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, JY; Chen, KB; Liao, CC; Liao, WW; Tsai, SY; Wen, YR; Yeh, GC	1

Other Studies

1 other study(ies) available for sb 216763 and Drug Withdrawal Symptoms

Article	Year
Coadministration of glycogen-synthase kinase 3 inhibitor with morphine attenuates chronic morphine-induced analgesic tolerance and withdrawal syndrome. Journal of the Chinese Medical Association : JCMA, 2014, Volume: 77, Issue:1 Topics: Aminophenols; Animals; Drug Combinations; Drug Tolerance; Glycogen Synthase Kinase 3; Indoles; Male; Maleimides; Morphine; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome	2014

Article

Year

Coadministration of glycogen-synthase kinase 3 inhibitor with morphine attenuates chronic morphine-induced analgesic tolerance and withdrawal syndrome.

Journal of the Chinese Medical Association : JCMA, 2014, Volume: 77, Issue:1

Topics: Aminophenols; Animals; Drug Combinations; Drug Tolerance; Glycogen Synthase Kinase 3; Indoles; Male; Maleimides; Morphine; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome

2014